See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated

Eli Lilly Article Archives

July 2014

BI-Lilly Alliance Creates Formidable Drug Development Combine

Pharma giants Boehringer Ingelheim (BI) and Eli Lilly and Company (Lilly) have formed the

comments 1 comment - Posted Jul 17, 2014

March 2014

FDA Delays Final OK for Type 2 Drug Empagliflozin

The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until "previously observed deficiencies" at the plant where it is manufactured are fixed.

comments 0 comments - Posted Mar 23, 2014

February 2014

Kris Freeman in Sochi: Type 1 Diabetes Skier- 4th Time Olympian

I remember first seeing Kris Freeman when he was 21 at a diabetes conference. Two years after he was diagnosed with type 1 diabetes, Eli Lilly began sponsoring his dream of becoming an Olympic cross-country skier. During his off-season, you can find Kris at diabetes camps inspiring children to follow their dream. He is the only person with diabetes to compete in a winter endurance sports event at the Olympics.

comments 1 comment - Posted Feb 7, 2014

November 2013

Promising New Type 2 Drug on Horizon

A new drug being developed by Eli Lilly Co. that duplicates the effects of a hormone may soon be added to the growing arsenal of pharmaceutical weapons available to treat type 2 diabetes.

comments 0 comments - Posted Nov 16, 2013

February 2013

Lilly Diabetes Supports Scholarship Fund With $100,000 Donation in 2013

Students with type 1 diabetes will have more opportunity for higher education thanks to a donation from Lilly Diabetes.

comments 0 comments - Posted Feb 9, 2013

September 2012

Lilly Launches Glucagon Mobile App

Lilly Diabetes recently launched the free Lilly Glucagon Mobile App to educate those who support people living with type 1 diabetes. The interactive app, available on the iTunes store for iPhone and iPad devices, provides caregivers, diabetes educators, and school nurses with visual and audio emergency instructions, as well as tools to track locations of glucagon kits and alerts for expiration dates.

comments 0 comments - Posted Sep 23, 2012

Boehringer and Lilly Introduce Online Program for Adult Type 2s

Boehringer Ingelheim Pharmaceuticals, Inc., and Eli Lilly and Company have introduced My Well Planner, a new online program offering customized educational content to help adults with type 2 diabetes make simple lifestyle changes to improve their health. Sample topics include general information about type 2 diabetes, better eating habits, building physical activity into daily life, taking medication, and communication strategies.

comments 0 comments - Posted Sep 22, 2012

June 2012

ADA Sessions Spotlight Powerful Weapons Against Diabetes

Several hopeful trends emerged from this year's ADA Scientific Sessions in Philadelphia, held June 8 through 12.

comments 0 comments - Posted Jun 23, 2012

March 2012

November 2011

Helping African Americans F.A.C.E. Their Risk for Diabetes

Diabetes Health publisher Nadia Al-Samarrie recently spoke with television and movie actor Anthony Anderson, who has taken a lead role with Eli Lilly & Company's F.A.C.E. campaign, a diabetes outreach to African Americans. A veteran of more than 20 films, Anthony, age 41, currently plays Detective Kevin Bernard on NBC's Emmy Award-winning drama, "Law & Order."

comments 1 comment - Posted Nov 27, 2011

July 2011

Tradjenta, a Drug for Type 2s, Now on U.S. Market

Boehringer Ingelheim and Eli Lilly have begun sales of Tradjenta, a drug for type 2 diabetes, in U.S. pharmacies. The drug (generic name linagliptin) comes in tablet form and is intended to compete with Amylin Pharmaceuticals' Byetta, which is injected, and Merck's Januvia, which also competes with Byetta. Both are well-established in the U.S. market.

comments 2 comments - Posted Jul 27, 2011

May 2011

Sanofi Says Late-Stage Trial of Type 2 Drug a Success

French drug maker Sanofi-aventis says that results from a Phase III trial of its experimental type 2 diabetes drug lixisenatide show that the drug successfully lowered patients' blood glucose levels and body weight, but did not increase the risk of hypoglycemia.

comments 0 comments - Posted May 23, 2011

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.